Clicky

Senseonics Holdings, Inc.(SENS)

Description: Senseonics Holdings, Inc., a medical technology company, focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. Its first generation continuous glucose monitoring system, Eversense measures glucose levels in people with diabetes for a period of up to 90 days. The company was founded in 1996 and is headquartered in Germantown, Maryland.


Keywords: Medicine Clinical Medicine Diabetes Medical Technology Medical Equipment Glucose Blood Test Medical Monitoring Diabetes Mellitus Blood Glucose Monitoring Continuous Glucose Monitor Glucose Monitoring Systems

Home Page: www.senseonics.com

SENS Technical Analysis

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States
Phone: 301 515 7260


Officers

Name Title
Dr. Timothy T. Goodnow Pres, CEO & Director
Dr. Mukul Jain Chief Operating Officer
Dr. Francine Ratner Kaufman M.D. Chief Medical Officer & Director
Mr. Frederick T. Sullivan CFO & Principal Accounting Officer
Mr. Kenneth L. Horton Gen. Counsel & Corp. Devel. Advisor

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)

Forward PE: 21.5054
Trailing PE: 9.7727
Price-to-Book MRQ: 12.4452
Price-to-Sales TTM: 36.4515
IPO Date: 2016-03-17
Fiscal Year End: December
Full Time Employees: 89
Back to stocks